Skip to main content
. 2008 Nov 24;26(36):5855–5862. doi: 10.1200/JCO.2008.16.8872

Table 1.

Symptom Severity Cut Points, Onset Time, Severity, and Response by Trial Arm

Symptom* and Intervention Arm Onset Time
Onset Severity No. % Nonresponse
Response
First Contact
Second or Later Contact
No. % No. % No. % No. %
Anxiety, 0-3, 4-5, 6-10
    NASM 17 51.5 16 48.5 Moderate 21 63.6 9 42.9 12 57.1
Severe 12 36.4 2 16.7 10 83.3
    ATSM 24 80.0 6 20.0 Moderate 19 63.3 1 5.3 18 94.7
Severe 11 36.7 2 18.2 9 81.8
Appetite, 0-3, 4-5, 6-10
    NASM 19 63.3 11 36.7 Moderate 18 60.0 4 22.2 14 77.8
Severe 12 40.0 1 8.3 11 91.7
    ATSM 19 67.9 9 32.1 Moderate 19 67.9 2 10.5 17 89.5
Severe 9 32.1 0 0 9 100.00
Constipation, 0-3, 4-6, 7-10
    NASM 9 60.0 6 40.0 Moderate 12 80.0 2 16.7 10 83.3
Severe 3 20.0 0 0 3 100.0
    ATSM 22 81.5 5 18.5 Moderate 17 63.0 2 11.8 15 88.2
Severe 10 37.0 2 20.0 8 80.0
Cough, 0-2, 3-4, 5-10
    NASM 11 64.7 6 35.3 Moderate 8 47.1 4 50.0 4 50.0
Severe 9 52.9 2 22.2 7 77.8
    ATSM 9 64.3 5 35.7 Moderate 4 28.6 1 25.0 3 75.0
Severe 10 71.4 0 0.00 10 100.0
Depression, 0-1, 2-3, 4-10
    NASM 15 62.5 9 37.5 Moderate
Severe 24 100.0 10 41.7 14 58.3
    ATSM 20 90.9 2 9.1 Moderate
Severe 22 100.0 4 18.2 18 81.8
Diarrhea, 0-3, 4-5, 6-10
    NASM 8 72.7 3 27.3 Moderate 5 45.5 1 20.0 4 80.0
Severe 6 54.5 1 16.7 5 83.3
    ATSM 7 63.6 4 36.4 Moderate 8 72.7 0 0 8 100.0
Severe 3 27.3 0 0 3 100.0
Dry mouth, 0-4, 5-8, 9-10
    NASM 18 62.1 11 37.9 Moderate 27 93.1 5 18.5 22 81.5
Severe 2 6.9 0 0 2 100.0
    ATSM 14 66.7 7 33.3 Moderate 17 81.0 4 23.5 13 76.5
Severe 4 19.0 1 25.0 3 75.0
Dyspnea, 0-2, 3-6, 7-10
    NASM 7 43.8 9 56.3 Moderate 14 87.5 9 64.3 5 35.7
Severe 2 12.5 0 0.00 2 100.0
    ATSM 11 64.7 6 35.3 Moderate 14 82.4 3 21.4 11 78.6
Severe 3 17.7 1 33.3 2 66.7
Fatigue, 0-1, 2-4, 5-10
    NASM 43 78.2 12 21.8 Moderate 15 27.3 11 73.3 4 26.7
Severe 40 72.7 17 42.5 23 57.5
    ATSM 39 73.6 14 25.4 Moderate 14 26.4 11 78.6 3 21.4
Severe 39 73.6 12 30.8 27 69.2
Vomiting, 0-3, 4-6, 7-10
    NASM 12 66.7 6 33.3 Moderate 13 72.2 2 15.4 11 84.6
Severe 5 27.8 0 0 5 100.0
    ATSM 14 66.7 7 33.3 Moderate 15 71.4 4 26.7 11 73.3
Severe 6 28.6 0 0 6 100.0
Pain, 0-1, 2-4, 5-10
    NASM 22 71.0 9 29.0 Moderate 16 51.6 5 31.3 11 68.7
Severe 15 48.4 5 33.3 10 66.7
    ATSM 13 72.2 5 27.8 Moderate 3 16.7 2 66.7 1 33.3
Severe 15 83.3 4 26.7 11 73.3
Peripheral neuropathy, 0-3, 4-7, 8-10
    NASM 8 66.7 4 33.3 Moderate 12 100.0 8 66.7 4 33.3
Severe 0 0 0 0 0 0
    ATSM 13 56.5 10 43.5 Moderate 19 82.6 3 15.8 16 84.2
Severe 4 17.4 1 25.0 3 75.0
Difficulty remembering, 0-1, 2-4, 5-10
    NASM 23 79.3 6 20.7 Moderate 14 48.3 8 57.1 6 42.9
Severe 15 51.7 4 26.7 11 73.3
    ATSM 15 88.2 2 11.8 Moderate 6 35.3 3 50.0 3 50.0
Severe 11 64.7 4 36.4 7 63.6
Sleep disturbance, 0-3, 4-6, 7-10
    NASM 28 73.7 10 26.3 Moderate 25 65.8 9 36.0 16 64.0
Severe 13 34.2 1 7.7 12 92.3
    ATSM 21 70.0 9 30.0 Moderate 17 56.7 5 29.4 12 70.6
Severe 13 43.3 2 15.4 11 84.6
Weakness, 0-2, 3-4, 5-10
    NASM 26 74.3 9 25.7 Moderate 15 42.9 7 46.7 8 53.3
Severe 20 57.1 5 25.0 15 75.0
    ATSM 18 69.2 8 30.8 Moderate 4 15.4 1 25.0 3 75.0
Severe 22 84.6 8 36.4 14 63.6

Abbreviations: NASM, Nurse-Administered Symptom Management; ATSM, Automated Telephone Symptom Management.

*

With ranges for none/mild, moderate, severe.

% is for each symptom, of those who ever reached threshold of 4 (or severity ≥ 5 for dry mouth) during intervention.